| | U.S. life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has "yet to convince" EU antitrust regulators scrutinising its $8 billion cash-and-stock bid for Grail Inc , people familiar with the matter said. | | | COVID-19-related restrictions on people's movements and interactions may be linked to a sharp decline in cases of mosquito-borne dengue fever in 2020, offering new insight into how it might be controlled, according to a study. | | | The Sackler family owners of Purdue Pharma LP reached a deal with a group of attorneys general to pay up to $6 billion in cash to resolve widespread litigation alleging that they fueled the U.S. opioid epidemic, bringing the OxyContin maker closer to exiting bankruptcy. | | | Medics will vaccinate about 2.9 million young children against polio in Malawi, the United Nations said on Thursday, after a three-year-old girl fell sick in the capital with Africa's first case of wild poliovirus in more than five years. | | | Austrian Health Minister Wolfgang Mueckstein resigned on Thursday, the second top official to step down within a year under the strain of tackling the coronavirus pandemic. | | | The U.S. Supreme Court on Thursday let Kentucky's Republican attorney general seek to restore a restrictive abortion law after the state's Democratic governor dropped defense of the statute when lower courts struck it down. | | | Eli Lilly and Incyte's arthritis drug baricitinib helped reduce the risk of death in hospitalised COVID-19 patients by 13% regardless of which other coronavirus treatment they were given, according to a large British study. | | | Western drugmakers and medical device companies warn their plans to keep selling products to Russia may be complicated by economic sanctions targeting the country and its major banks in punishment over Moscow's invasion of Ukraine. | | | COVID-19 cases in Sweden are falling sharply, the country's health agency said on Thursday, even as nearly all pandemic-related restrictions were lifted less than a month ago. | | | The European Medicines Agency's leading vaccine expert said he was not concerned over recent data from New York state on a decline of protection from the Pfizer and BioNTech SE COVID-19 vaccine in children aged 5 to 11. | | | | |